AI-enabled Diagnostic Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511243161

Publication Date:

November 28, 2024

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for AI-enabled Diagnostic Imaging was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AI-enabled Diagnostic Imaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI-enabled Diagnostic Imaging by region & country, by Type, and by Application.
The AI-enabled Diagnostic Imaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-enabled Diagnostic Imaging.
Market Segmentation
By Company
Siemens Healthineers
Nuance Communication
Koninklijke Philips
Arterys
Samsung Electronics
Zebra Medical Vision
Bay Labs
IBM Corporation
NVIDIA
Alibaba Cloud
Neusoft
Segment by Type:
Software
Service
Segment by Application
Hospitals
R&D centers
Laboratories and Diagnostic centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of AI-enabled Diagnostic Imaging manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of AI-enabled Diagnostic Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of AI-enabled Diagnostic Imaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 AI-enabled Diagnostic Imaging Product Introduction
1.2 Global AI-enabled Diagnostic Imaging Market Size Forecast
1.3 AI-enabled Diagnostic Imaging Market Trends & Drivers
1.3.1 AI-enabled Diagnostic Imaging Industry Trends
1.3.2 AI-enabled Diagnostic Imaging Market Drivers & Opportunity
1.3.3 AI-enabled Diagnostic Imaging Market Challenges
1.3.4 AI-enabled Diagnostic Imaging Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global AI-enabled Diagnostic Imaging Players Revenue Ranking (2023)
2.2 Global AI-enabled Diagnostic Imaging Revenue by Company (2019-2024)
2.3 Key Companies AI-enabled Diagnostic Imaging Manufacturing Base Distribution and Headquarters
2.4 Key Companies AI-enabled Diagnostic Imaging Product Offered
2.5 Key Companies Time to Begin Mass Production of AI-enabled Diagnostic Imaging
2.6 AI-enabled Diagnostic Imaging Market Competitive Analysis
2.6.1 AI-enabled Diagnostic Imaging Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by AI-enabled Diagnostic Imaging Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-enabled Diagnostic Imaging as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Software
3.1.2 Service
3.2 Global AI-enabled Diagnostic Imaging Sales Value by Type
3.2.1 Global AI-enabled Diagnostic Imaging Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global AI-enabled Diagnostic Imaging Sales Value, by Type (2019-2030)
3.2.3 Global AI-enabled Diagnostic Imaging Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 R&D centers
4.1.3 Laboratories and Diagnostic centers
4.1.4 Others
4.2 Global AI-enabled Diagnostic Imaging Sales Value by Application
4.2.1 Global AI-enabled Diagnostic Imaging Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global AI-enabled Diagnostic Imaging Sales Value, by Application (2019-2030)
4.2.3 Global AI-enabled Diagnostic Imaging Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global AI-enabled Diagnostic Imaging Sales Value by Region
5.1.1 Global AI-enabled Diagnostic Imaging Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global AI-enabled Diagnostic Imaging Sales Value by Region (2019-2024)
5.1.3 Global AI-enabled Diagnostic Imaging Sales Value by Region (2025-2030)
5.1.4 Global AI-enabled Diagnostic Imaging Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America AI-enabled Diagnostic Imaging Sales Value, 2019-2030
5.2.2 North America AI-enabled Diagnostic Imaging Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe AI-enabled Diagnostic Imaging Sales Value, 2019-2030
5.3.2 Europe AI-enabled Diagnostic Imaging Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific AI-enabled Diagnostic Imaging Sales Value, 2019-2030
5.4.2 Asia Pacific AI-enabled Diagnostic Imaging Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America AI-enabled Diagnostic Imaging Sales Value, 2019-2030
5.5.2 South America AI-enabled Diagnostic Imaging Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa AI-enabled Diagnostic Imaging Sales Value, 2019-2030
5.6.2 Middle East & Africa AI-enabled Diagnostic Imaging Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AI-enabled Diagnostic Imaging Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions AI-enabled Diagnostic Imaging Sales Value
6.3 United States
6.3.1 United States AI-enabled Diagnostic Imaging Sales Value, 2019-2030
6.3.2 United States AI-enabled Diagnostic Imaging Sales Value by Type (%), 2023 VS 2030
6.3.3 United States AI-enabled Diagnostic Imaging Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe AI-enabled Diagnostic Imaging Sales Value, 2019-2030
6.4.2 Europe AI-enabled Diagnostic Imaging Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe AI-enabled Diagnostic Imaging Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China AI-enabled Diagnostic Imaging Sales Value, 2019-2030
6.5.2 China AI-enabled Diagnostic Imaging Sales Value by Type (%), 2023 VS 2030
6.5.3 China AI-enabled Diagnostic Imaging Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan AI-enabled Diagnostic Imaging Sales Value, 2019-2030
6.6.2 Japan AI-enabled Diagnostic Imaging Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan AI-enabled Diagnostic Imaging Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea AI-enabled Diagnostic Imaging Sales Value, 2019-2030
6.7.2 South Korea AI-enabled Diagnostic Imaging Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea AI-enabled Diagnostic Imaging Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia AI-enabled Diagnostic Imaging Sales Value, 2019-2030
6.8.2 Southeast Asia AI-enabled Diagnostic Imaging Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia AI-enabled Diagnostic Imaging Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India AI-enabled Diagnostic Imaging Sales Value, 2019-2030
6.9.2 India AI-enabled Diagnostic Imaging Sales Value by Type (%), 2023 VS 2030
6.9.3 India AI-enabled Diagnostic Imaging Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Siemens Healthineers
7.1.1 Siemens Healthineers Profile
7.1.2 Siemens Healthineers Main Business
7.1.3 Siemens Healthineers AI-enabled Diagnostic Imaging Products, Services and Solutions
7.1.4 Siemens Healthineers AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.1.5 Siemens Healthineers Recent Developments
7.2 Nuance Communication
7.2.1 Nuance Communication Profile
7.2.2 Nuance Communication Main Business
7.2.3 Nuance Communication AI-enabled Diagnostic Imaging Products, Services and Solutions
7.2.4 Nuance Communication AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.2.5 Nuance Communication Recent Developments
7.3 Koninklijke Philips
7.3.1 Koninklijke Philips Profile
7.3.2 Koninklijke Philips Main Business
7.3.3 Koninklijke Philips AI-enabled Diagnostic Imaging Products, Services and Solutions
7.3.4 Koninklijke Philips AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.3.5 Arterys Recent Developments
7.4 Arterys
7.4.1 Arterys Profile
7.4.2 Arterys Main Business
7.4.3 Arterys AI-enabled Diagnostic Imaging Products, Services and Solutions
7.4.4 Arterys AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.4.5 Arterys Recent Developments
7.5 Samsung Electronics
7.5.1 Samsung Electronics Profile
7.5.2 Samsung Electronics Main Business
7.5.3 Samsung Electronics AI-enabled Diagnostic Imaging Products, Services and Solutions
7.5.4 Samsung Electronics AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.5.5 Samsung Electronics Recent Developments
7.6 Zebra Medical Vision
7.6.1 Zebra Medical Vision Profile
7.6.2 Zebra Medical Vision Main Business
7.6.3 Zebra Medical Vision AI-enabled Diagnostic Imaging Products, Services and Solutions
7.6.4 Zebra Medical Vision AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.6.5 Zebra Medical Vision Recent Developments
7.7 Bay Labs
7.7.1 Bay Labs Profile
7.7.2 Bay Labs Main Business
7.7.3 Bay Labs AI-enabled Diagnostic Imaging Products, Services and Solutions
7.7.4 Bay Labs AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.7.5 Bay Labs Recent Developments
7.8 IBM Corporation
7.8.1 IBM Corporation Profile
7.8.2 IBM Corporation Main Business
7.8.3 IBM Corporation AI-enabled Diagnostic Imaging Products, Services and Solutions
7.8.4 IBM Corporation AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.8.5 IBM Corporation Recent Developments
7.9 NVIDIA
7.9.1 NVIDIA Profile
7.9.2 NVIDIA Main Business
7.9.3 NVIDIA AI-enabled Diagnostic Imaging Products, Services and Solutions
7.9.4 NVIDIA AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.9.5 NVIDIA Recent Developments
7.10 Alibaba Cloud
7.10.1 Alibaba Cloud Profile
7.10.2 Alibaba Cloud Main Business
7.10.3 Alibaba Cloud AI-enabled Diagnostic Imaging Products, Services and Solutions
7.10.4 Alibaba Cloud AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.10.5 Alibaba Cloud Recent Developments
7.11 Neusoft
7.11.1 Neusoft Profile
7.11.2 Neusoft Main Business
7.11.3 Neusoft AI-enabled Diagnostic Imaging Products, Services and Solutions
7.11.4 Neusoft AI-enabled Diagnostic Imaging Revenue (US$ Million) & (2019-2024)
7.11.5 Neusoft Recent Developments
8 Industry Chain Analysis
8.1 AI-enabled Diagnostic Imaging Industrial Chain
8.2 AI-enabled Diagnostic Imaging Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 AI-enabled Diagnostic Imaging Sales Model
8.5.2 Sales Channel
8.5.3 AI-enabled Diagnostic Imaging Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Siemens Healthineers
Nuance Communication
Koninklijke Philips
Arterys
Samsung Electronics
Zebra Medical Vision
Bay Labs
IBM Corporation
NVIDIA
Alibaba Cloud
Neusoft

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂